1 citations
,
December 2022 in “Actas dermo-sifiliográficas/Actas dermo-sifiliográficas” This review discusses the characteristics, triggers, and individualized treatment options for sensitive scalp but presents no new research findings.
8 citations
,
October 2022 in “Regenerative Therapy” This review discusses regenerative medicine approaches for treating alopecia, including mesenchymal stem cell therapies and platelet-rich plasma, but reports no new clinical results, emphasizing the need for further study.
2 citations
,
September 2022 in “Actas dermo-sifiliográficas/Actas dermo-sifiliográficas” This article discusses the sensitive skin condition of the scalp, its clinical manifestations, triggers, and individualized treatment options, but reports no new clinical results.
1 citations
,
January 2022 in “Dermatology Reports” This study reported that sensitive scalp symptoms, including trichodynia, are frequently found in hair loss patients, particularly among those with telogen effluvium and alopecia areata.
2 citations
,
January 2022 in “Anais brasileiros de dermatologia/Anais Brasileiros de Dermatologia” This review discusses the effects of chemical hair straighteners and reports associated side effects like scalp inflammation and hair damage, noting the variability of findings and the need for further research.
4 citations
,
January 2021 in “Skin appendage disorders” This review discusses the complex causes of trichodynia and reports no clinical results; the authors call for more research into neural and immune interactions in scalp conditions.
8 citations
,
March 2020 in “Pain Medicine” This case report describes a woman with refractory trichodynia who became asymptomatic after receiving botulinum toxin type A injections, suggesting potential efficacy of this treatment for persistent trichodynia.
4 citations
,
January 2019 in “Dermatology Online Journal” This article discusses the potential of low-dose naltrexone as an adjuvant therapy for trichodynia in alopecias, noting its anti-inflammatory properties and need for further research.
25 citations
,
December 2017 in “Facial Plastic Surgery” This study observed that combining high-potency steroids with pimecrolimus might effectively stabilize hairline recession in frontal fibrosing alopecia patients.
39 citations
,
November 2017 in “PubMed” This case series reported that low-dose naltrexone may benefit patients with lichen planopilaris by reducing scalp symptoms and slowing disease progression, with no adverse effects observed in the patients.
26 citations
,
December 2015 in “International Journal of Dermatology” This abstract reviews the symptom of trichodynia, a painful scalp sensation linked to hair loss, and highlights its potential connection to inflammation but reports no new research findings.
8 citations
,
September 2015 in “Journal of the European Academy of Dermatology and Venereology” This study observed that hair and scalp sensations were significantly more common and intense in chemotherapy patients compared to those receiving tamoxifen, with sensations ceasing after 11 weeks.
4 citations
,
July 2015 in “Clinical, cosmetic and investigational dermatology” In this study, a new hypertolerant shampoo significantly reduced scabbing and erythema after hair transplantation, demonstrating excellent skin compatibility and suitability for sensitive scalp care.
68 citations
,
February 2015 in “Journal of the European Academy of Dermatology and Venereology” This study found that severe folliculitis decalvans was associated with its onset before age 25 and the presence of pustules, while tetracyclines and clindamycin plus rifampicin were effective treatments.
11 citations
,
January 2014 in “International Journal of Trichology” This study observed that patients using Erol(®) Energy shampoo and tonic reported improved symptoms of scalp irritation and rated product tolerance as good to excellent.
33 citations
,
April 2009 in “Clinical and Experimental Dermatology” This study observed that psychological factors and serum levels of zinc, folate, and vitamin B12 may contribute to the development of trichodynia.
24 citations
,
March 2009 in “Journal of the European Academy of Dermatology and Venereology” This paper highlights trichodynia as a distinguishing symptom of telogen effluvium, but it does not present new clinical findings.
80 citations
,
March 2008 in “Contact Dermatitis” This study found that scalp sensitivity frequently occurs in the French population and is associated with various symptoms and triggers, differing from facial skin sensitivity.
46 citations
,
September 2003 in “International Journal of Dermatology” This study found that trichodynia is common among patients with telogen effluvium and androgenetic alopecia, and it often coexists with psychological issues like depression and anxiety.
48 citations
,
January 2002 in “Dermatology” In this study, hair pain (trichodynia) was reported by a significant portion of patients with hair loss, but it did not correlate with the cause or activity of the condition.
138 citations
,
March 2001 in “Clinics in Dermatology” This review discusses the relationship between perceived stress and hair loss or graying, exploring hair follicles as a model system but reports no new clinical results.
